Risks of diabetic foot syndrome and amputation associated with sodium glucose co-transporter 2 inhibitors: A Meta-analysis of Randomized Controlled Trials-Reference-Cited by-同舟云学术

Risks of diabetic foot syndrome and amputation associated with sodium glucose co-transporter 2 inhibitors: A Meta-analysis of Randomized Controlled Trials

Published:2018-11 Issue:5 Volume:44 Page:410-414
ISSN:1262-3636
Container-title:Diabetes & Metabolism
language:en
Short-container-title:Diabetes & Metabolism

Author:

Li D.,Yang J. Yufeng,Wang T.,Shen S.,Tang H.

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference33 articles.

1. Preventing foot ulcers in patients with diabetes;Singh;JAMA,2005

2. Pathways to diabetic limb amputation. Basis for prevention;Pecoraro;Diabetes Care,1990

3. Direct medical costs of complications of diabetes in the United States: estimates for event-year and annual state costs (USD 2012);Ward;J Med Econ,2014

4. A systematic review and meta-analysis of glycemic control for the prevention of diabetic foot syndrome;Hasan;J Vasc Surg,2016

5. SGLT2 inhibition in diabetes mellitus: rationale and clinical prospects;Ferrannini;Nat Rev Endocrinol,2012

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sodium glucose cotransporter-2 inhibitors and heart disease: Current perspectives;World Journal of Cardiology;2024-05-26

2. Factors associated with diabetic foot ulcers and lower limb amputations in type 1 and type 2 diabetes supported by real‐world data from the German/Austrian DPV registry;Journal of Diabetes;2024-02

3. Risk Factors for Lower Extremity Amputation among Diabetic Patients with Diabetic Foot Gangrene in ATBUTH, Bauchi;Open Journal of Orthopedics;2024

4. Diagnostic significance of endotoxin and antitoxic opsonin – fibronectin in the blood flow in purulent-necrotic inflammatory of the lower limb in patients with diabetes mellitus;Ambulatornaya khirurgiya = Ambulatory Surgery (Russia);2023-11-22

5. Safety of sodium‐glucose co‐transporter‐2 inhibitors on amputation across categories of baseline cardiovascular disease and diuretics use in patients with type 2 diabetes;Diabetes, Obesity and Metabolism;2023-07-28